Clinical Trial

The NUTRIOME Study - a Data-driven Precision Nutrition Intervention

Study acronym: NUTRIOME
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 21, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The overall objective of this multi-center study is to use metabolic response data from different dietary challenges to develop personalized dietary advice. Effectiveness of this personalized dietary advice compared to a general healthy diet based on national dietary guidelines on markers of cardio-metabolic health will be tested. A total of 120 men and women who meet all inclusion criteria and none of the exclusion criteria will be invited to participate. The study will be conducted at three sites: Chalmers University of Technology (Sweden), University of Wageningen (Netherlands), and University of Oslo (Norway), with 40 participants per site.The study is conducted in two parts. The first part, the characterization phase, is a three-way randomized, controlled cross-over design, featuring one-day meal tests with isocaloric meals containing different carbohydrate, fat and protein quantity as well as quality. Based on the metabolic response to the meal tests a personalized diet will be constructed. In the second part, the main intervention, effectiveness of this personalized dietary advice compared to a general healthy diet will be tested in a six week parallel group intervention study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-19.
Status change: Not Yet Recruiting → Recruiting 2025-03-20
Trial Details
NCT Number NCT06842433
Lead Sponsor Chalmers University of Technology
Collaborators: University of Oslo, Wageningen University, Polish Academy of Sciences, Maastricht University, German Cancer Research Center, University of Copenhagen, University of Oulu, University College Dublin
Conditions Metabolic Control
Enrollment 120 participants
Start Date 2025-03-14
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-21